January 15, 2015

Beiersdorf — whose brands include Nivea, Eucerin and La Prairie — announced on Thursday that it continued its profitable growth path in 2014 despite a challenging macroeconomic environment.

December 10, 2014

"For small- to medium-sized U.S. OTC manufacturers, the choice of going global usually forces a tough choice: selling directly to one or two important key accounts vs. working with a local distributor partner," writes Ed Rowland, founder and managing partner of Rowland Global LLC, in his latest blog post. 

 

August 13, 2014

The European Union is leading an international pilot project through which, upon request from a generic pharmaceutical company, it will share the assessment reports generated as part of the decentralized procedure in real time with collaborating regulatory agencies outside the EU.

August 7, 2014

Beiersdorf released results for the first half of the year and recorded a lift in sales of Nivea and Eucerin brands in the Consumer Business Segment.

May 14, 2014

The U.S. Department of Health and Human Services and the European Commission on Tuesday released the first progress report of the Transatlantic Taskforce on Antimicrobial Resistance.

April 15, 2014

Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by Design, on Tuesday announced that it has entered into a global licensing agreement with Mylan for its leading inhaled respiratory products, PSX1001 and PSX1050.

March 4, 2014

Beiersdorf, whose portfolio includes Nivea and Eucerin, enjoyed a “successful” 2013 as sales growth exceeded expectations.

December 18, 2013

The Food and Drug Administration and the European Medicines Agency will share data about studies meant to show whether generic drugs are equivalent to their branded counterparts, under a joint program announced Wednesday.

November 6, 2013

Skin care brand Beiersdorf reported that its consumer business segment achieved “significant, above-market sales growth” during the first nine months of 2013, with both Nivea and Eucerin enjoying a boost in sales.

October 11, 2013

The global market for drugs to treat constipation resulting from use of opioid painkillers will increase more than tenfold by 2017, according to new research.

October 10, 2013

When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.

September 10, 2013

European regulators have approved the European Union's first biosimilar monoclonal antibody. The new product, made by U.S.-based Hospira, comes seven years after the approval of Europe's first biosimilar.

August 14, 2013

Global skin care brand Beiersdorf, whose brands include Nivea and Eurcerin, reported that, for the first half of 2013, it continued to progress well with solid sales growth in both business segments — Consumer and tesa.

July 9, 2013

Amgen will get rights to a drug for cardiovascular disease approved in the European Union under a new deal with French drug maker Servier, the two companies said.

May 7, 2013

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.

May 2, 2013

Skin care brand Beiersdorf announced on Thursday that it has “continued last year’s positive trend in the first quarter of 2013.”

January 30, 2013

A ban on importing and selling animal-tested cosmetics products and ingredients will enter into force in March. The ban affects all cosmetics, including toiletries and beauty products.

November 12, 2012

Procter & Gamble and Teva Pharmaceutical on Monday gained European Union approval for a joint venture on the sale of nonprescription medicines to be called PGT Healthcare, according to published reports.

December 23, 2011

Rather than take off for Christmas, the editors of Drug Store News took a look at the year ahead and the stories, issues and trends that will make headlines in retail pharmacy in 2012.

August 24, 2011


A worldwide flood of counterfeit and unsafe medications is seeping into the United States and other developed countries via the Internet and porous borders, threatening public health and the security of the pharmaceutical supply chain.

June 6, 2011

The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

May 17, 2011

An investigational drug made by InterMune improved breathing in patients with a rare and fatal lung disease, according to results of a late-stage clinical trial published online in The Lancet last week.

March 29, 2011

Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

July 11, 2010

Ranir, an oral care consumer products company, has acquired Synpart Limited and Synpart AG from...